World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
33704
World Ranking
11241
National Ranking
5771

Biology and Biochemistry

D-Index
92
Citations
33814
World Ranking
2199
National Ranking
1187

Henry C. Pitot publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Henry C. Pitot sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 481 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Henry C. Pitot D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Henry C. Pitot sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 92 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 1982 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Henry C. Pitot was affiliated with the University of Wisconsin-Madison in the United States and contributed extensively to the field of medicine. Their research focused on several subfields, particularly oncology, pulmonary and respiratory medicine, surgery, pathology and forensic medicine, and molecular biology.

Their work spanned a variety of topics, including:

  • Colorectal Cancer Treatments and Studies
  • Gastric Cancer Management and Outcomes
  • Pancreatic and Hepatic Oncology Research
  • Esophageal Cancer Research and Treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers

Henry C. Pitot published frequently in the following venues:

  • Journal of Clinical Oncology
  • UNC Libraries
  • Clinical Cancer Research
  • Cancers
  • International Journal of Cancer

Some of their recent publications included:

  • "A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer" (2023, Journal of Clinical Oncology)
  • "Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction" (2022, Clinical Cancer Research)
  • "Estrogen Receptor-α Suppresses Liver Carcinogenesis and Establishes Sex-Specific Gene Expression" (2021, Cancers)
  • "Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma" (2021, International Journal of Cancer)
  • "Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan-based chemotherapy in patients with pancreas cancer" (2020, Pancreatology)

The scientist collaborated frequently with several co-authors, including:

  • Richard M. Goldberg
  • Harry H. Yoon
  • Qian Shi
  • Daniel J. Sargent
  • Zhaohui Jin

Henry C. Pitot was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 1982.

Best Publications

  • A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

    Richard M. Goldberg;Daniel J. Sargent;Roscoe F. Morton;Charles S. Fuchs

  • A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse

    Amy Rapaich Moser;Henry C. Pitot;William F. Dove

  • Primary culture of parenchymal liver cells on collagen membranes. Morphological and biochemical observations.

    G. Michalopoulos;H.C. Pitot

  • The stages of initiation and promotion in hepatocarcinogenesis.

    Henry C. Pitot;Alphonse E. Sirica

  • Pathology of mouse models of intestinal cancer: Consensus report and recommendations

    Gregory P. Boivin;Kay Washington;Kan Yang;Jerrold M. Ward

  • Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

    Jan Franko;Qian Shi;Charles D. Goldman;Barbara A. Pockaj

  • Biochemical characterisation of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine

    Henry C. Pitot;Lona Barsness;Tom Goldsworthy;Tomoyuki Kitagawa

  • Use of a low-speed, iso-density percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations.

    B. L. Kreamer;J. L. Staecker;N. Sawada;G. L. Sattler

  • Quantitative Evaluation of the Promotion by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of Hepatocarcinogenesis from Diethylnitrosamine

    Henry C. Pitot;Thomas Goldsworthy;H. A. Campbell;Alan Poland

  • Gamma-glutamyl transpeptidase--its role in hepatocarcinogenesis.

    Marie H. Hanigan;Henry C. Pitot

  • Phase II Study of Erlotinib in Patients With Advanced Biliary Cancer

    Philip A. Philip;Michelle R. Mahoney;Cristine Allmer;James Thomas

  • The Human Papillomavirus Type 16 E6 Gene Alone Is Sufficient To Induce Carcinomas in Transgenic Animals

    Shiyu Song;Henry C. Pitot;Paul F. Lambert

  • Fetal phenotypic expression by adult rat hepatocytes on collagen gel/nylon meshes.

    Alphonse E. Sirica;William Richards;Yutaka Tsukada;Carol A. Sattler

  • Facts and theories concerning the mechanisms of carcinogenesis.

    Henry C. Pitot;Yvonne P. Dragan

  • Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.

    Patrick A. Burch;Jami K. Breen;Jan C. Buckner;Dennis A. Gastineau

  • Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study.

    Sam J. Lubner;Michelle R. Mahoney;Jill L. Kolesar;Noelle K. LoConte

  • Randomized Controlled Trial of Reduced-Dose Bolus Fluorouracil Plus Leucovorin and Irinotecan or Infused Fluorouracil Plus Leucovorin and Oxaliplatin in Patients With Previously Untreated Metastatic Colorectal Cancer: A North American Intergroup Trial

    Richard M. Goldberg;Daniel J. Sargent;Roscoe F. Morton;Charles S. Fuchs

  • Application of Quantitative Stereology to the Evaluation of Enzymealtered Foci in Rat Liver

    H. A. Campbell;H. C. Pitot;Van R. Potter;B. A. Laishes

  • A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.

    Henry C. Pitot;Thomas L. Goldsworthy;Susan Moran;Wendy Kennan

  • The molecular biology of carcinogenesis.

    Henry C. Pitot

Frequent Co-Authors

Van R. Potter
Van R. Potter University of Wisconsin–Madison
Paul F. Lambert
Paul F. Lambert University of Wisconsin–Madison
Richard M. Goldberg
Richard M. Goldberg West Virginia University
George K. Michalopoulos
George K. Michalopoulos University of Pittsburgh
James A. Miller
James A. Miller University of Wisconsin–Madison
Harold P. Morris
Harold P. Morris Howard University
Philip A. Philip
Philip A. Philip Wayne State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Advancing your education in Biology or Biochemistry opens the door to many health science fields. For those seeking flexibility, many programs now exist fully online, allowing you to balance studies with other commitments. One entry point into healthcare is medical billing and coding, a role that plays a vital part in the management of medical records and healthcare information. If you’re wondering whether this field aligns with your goals, our guide on is medical billing and coding worth it covers the key advantages and challenges.

Those interested in more advanced study may explore options like a online master's degree in nutrition, which can lead to careers in dietetics, health education, or research. Similarly, earning an him degree online prepares you for managing electronic health records—an area in high demand as healthcare becomes increasingly digitized.

For those drawn to diagnostic imaging, sonography programs online offer training that can lead directly to clinical roles as ultrasound technicians. Carefully consider which online pathway supports your professional interests, personal strengths, and career ambitions in the life sciences.

Best Scientists Citing Henry C. Pitot

Recently Published Articles